MartinaPorterMD

Physician

Dr. Porter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospFellowship, Dermatology, 2016 - 2017
Roger Williams Medical CenterResidency, Dermatology, 2016
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 2013 - 2014
Drexel University College of MedicineClass of 2013
Roger Williams Medical CenterChief Residency, Dermatology

PubMed

Biologics in hidradenitis suppurativa: Progress and new directions.
Alexandra Charrow, Karla Santiago-Soltero, Martina Porter
Journal of the American Academy of Dermatology. 2024-12-01
Advances in Hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances 2023.
Sarah Park, Alexis Bell, Ruby Gibson, Rahul Masson, Steven Daveluy
The Journal of Investigative Dermatology. 2024-08-01
5 citations
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, do...
Joslyn S Kirby, Martin M Okun, Afsaneh Alavi, Falk G Bechara, Christos C Zouboulis
Journal of the American Academy of Dermatology. 2024-03-01

Lectures

Predictions, Surprises, and the Future of the Dermatology Workforce
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Elderly Patients with Nonmelanoma Skin Cancer More Likely to Go UntreatedSeptember 24th, 2019
Reply to: Lack of a US Food and Drug Administration Indication Should Not Limit Access to TreatmentMarch 23rd, 2019
Mind the Gap: Disparity Between Urban and Rural Derms WidensSeptember 6th, 2018
Join now to see all